Journal
FUTURE MICROBIOLOGY
Volume 4, Issue 2, Pages 189-200Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/17460913.4.2.189
Keywords
antibiotic resistance; Campylobacter; ecological fitness; fluoroquinolone; food safety; macrolide; public health
Categories
Funding
- NIH [RO1DK063008]
- US Department of Agriculture Cooperative State Research, Education and Extension Services [2005-51110-03273, 2006-34211-17310]
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063008] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Campylobacter is a leading foodborne bacterial pathogen, which causes gastroenteritis in humans, This pathogenic organism is increasingly resistant to antibiotics, especially fluoroquinolones and macrolides, which are the most frequently used antimicrobials for the treatment of campylobacteriosis when clinical therapy is warranted. As a zoonotic pathogen, Campylobacter has a broad animal reservoir and infects humans via contaminated food, water or milk. Antibiotic usage in both animal agriculture and human medicine, can influence the development of antibiotic-resistant Campylobacter. This review will describe the trend in fluoroquinolone and macrolide resistance in Campylobacter, summarize the mechanisms underlying the resistance to various antibiotics and discuss the unique features associated with the emergence, transmission and persistence of antibiotic-resistant Campylobacter, Special attention will be given to recent findings and emphasis will be placed on Campylobacter resistance to fluoroquinolones and macrolides. A future perspective on antibiotic resistance and potential approaches for the control of antibiotic-resistant Campylobacter, will also be discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available